HOME > Our Business > Prescription Pharmaceutical > Main Products

Main Products

In our prescription pharmaceutical operations, our main products are prescribed at various medical fronts and sold not only in domestic markets but also in countries worldwide.

The main product lineups include Clarith, a macrolide antibiotic; Lusefi, type 2 diabetes mellitus agent; LOQOA, transdermal anti-inflammatory analgesic.

Taisho works to develop market-oriented products, the company is striving to deliver a comprehensive lineup of medications and treatments to help people in Japan and around the world lead richer lives by improving their health.